Keywords
non-small-cell lung cancer (NSCLC)
lung cancer
prognostic factors
systemic inflammation index
neutrophil to lymphocyte ratio
surgical treatment
lung cancer
prognostic factors
systemic inflammation index
neutrophil to lymphocyte ratio
surgical treatment
Abstract
Nowadays, inflammatory cell sin peripheral blood are considered as prognostic factors in different malignancies. The aim of this study was to identify the prognostic value of pretreatment blood inflammatory biomarkers for patients undergoing surgery for I–II stages of non-smallcell lung cancer (NSCLC).
Methods. A single-center retrospective review from 2003 to 2017 enrolled 403 patients with early stages of NSCLC who underwent surgical resection in our hospital.